Amgen/Chugai EPO ruling
Executive Summary
Will be reviewed by the full International Trade Commission. The ITC commissioners will evaluate the Jan. 10 initial determination by ITC Administrative Law Judge Sydney Harris that would allow Chugai to continue to import erythropoietin (EPO) into the U.S. The Commission has until April 10 to make a final decision to uphold or overturn the ALJ's ruling.